Publications dans lesquelles il/elle collabore avec Jackeline Agorreta Arrazubi (5)

2021

  1. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2019

  1. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

    Thorax, Vol. 74, Núm. 4, pp. 371-379

  2. YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

    American Journal of Respiratory and Critical Care Medicine, Vol. 200, Núm. 7, pp. 888-899

2018

  1. The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer

    Laboratory Investigation, Vol. 98, Núm. 12, pp. 1562-1574

2006

  1. Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features

    Cancer Epidemiology Biomarkers and Prevention, Vol. 15, Núm. 2, pp. 373-380